.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Cisatracurium besylate - Generic Drug Details

« Back to Dashboard
Cisatracurium besylate is the generic ingredient in four branded drugs marketed by Abbvie, Sandoz Inc, and Fresenius Kabi Usa, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for cisatracurium besylate. Three suppliers are listed for this compound.

Summary for Generic Name: cisatracurium besylate

Tradenames:4
Patents:0
Applicants:3
NDAs:5
Drug Master File Entries: see list9
Suppliers / Packaging: see list3

Pharmacology for Ingredient: cisatracurium besylate

Clinical Trials for: cisatracurium besylate

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz Inc
CISATRACURIUM BESYLATE
cisatracurium besylate
INJECTABLE;INJECTION200159-001Feb 3, 2012RXNo<disabled><disabled>
Abbvie
NIMBEX
cisatracurium besylate
INJECTABLE;INJECTION020551-001Dec 15, 1995RXYes<disabled><disabled>
Fresenius Kabi Usa
CISATRACURIUM BESYLATE PRESERVATIVE FREE
cisatracurium besylate
INJECTABLE;INJECTION203182-002Feb 26, 2015RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: cisatracurium besylate

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie
NIMBEX
cisatracurium besylate
INJECTABLE;INJECTION020551-001Dec 15, 19954,179,507<disabled>
Abbvie
NIMBEX PRESERVATIVE FREE
cisatracurium besylate
INJECTABLE;INJECTION020551-003Dec 15, 19954,179,507<disabled>
Abbvie
NIMBEX PRESERVATIVE FREE
cisatracurium besylate
INJECTABLE;INJECTION020551-002Dec 15, 19954,179,507<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc